Belgium based Mithra Pharmaceuticals, on Tuesday, said it is scouting for suitable distribution partners in India to launch its women healthcare products in the country.
The company, which is dedicated to women healthcare products, has presence in four therapeutic fields, such as contraception and fertility, menopause and osteoporosis, utero vaginal and female cancer segments. Mithra Pharmaceuticals, a spin-off of the University of Liege, has a market share of over 42 per cent in Belgium in contraceptive range and has distribution rights in 44 countries across the globe.
Francois Fornieri, CEO and founder, Mithra Pharmaceuticals, said, “We would like to collaborate with Indian companies to launch our product portfolio in India. We would like to team up with companies who are a specialist in women healthcare. But we are open to other companies who are not women-centric portfolio as well since we want to collaborate on the development side as well. We would like to team up with companies for research-level partnership as well.”
Fornieri was in town to announce the launch of Mithra Campus, a state-of-the-art campus which will provide an innovative and regulatory platform to enable and facilitate increased presence and access to the European market for Indian pharmaceuticals companies.
Ashish Sehgal, business consultant with Mithra Pharmaceuticals, said, “The campus is well-positioned to address the current challenges of the Indian pharma industry both in terms of infrastructure and collaborative eco-system. The campus will act as the access point for Indian pharma companies to enter the European market and increase their business and value proposition.”
Valerie Gordenne, CSO, Mithra Pharmaceuticals, said, “We are GMP and cGMP compliant and we have the know-how to offer regulatory support to the Indian companies to enter the European market. We definitely want to collaborate on the research level as well.”
The company, once it ties-up with Indian companies, expects to launch contraceptive products in the Indian market followed by oncology and other products. “The first line of product is likely to be contraceptive and then may be oncology, in breast-cancer and cervical cancer space. We may then look at menopausal and other lines of products,” said Garrick Colle of Mithra
Source: http://www.mydigitalfc.com/news/mithra-seeks-distribution-partners-india-870
The company, which is dedicated to women healthcare products, has presence in four therapeutic fields, such as contraception and fertility, menopause and osteoporosis, utero vaginal and female cancer segments. Mithra Pharmaceuticals, a spin-off of the University of Liege, has a market share of over 42 per cent in Belgium in contraceptive range and has distribution rights in 44 countries across the globe.
Francois Fornieri, CEO and founder, Mithra Pharmaceuticals, said, “We would like to collaborate with Indian companies to launch our product portfolio in India. We would like to team up with companies who are a specialist in women healthcare. But we are open to other companies who are not women-centric portfolio as well since we want to collaborate on the development side as well. We would like to team up with companies for research-level partnership as well.”
Fornieri was in town to announce the launch of Mithra Campus, a state-of-the-art campus which will provide an innovative and regulatory platform to enable and facilitate increased presence and access to the European market for Indian pharmaceuticals companies.
Ashish Sehgal, business consultant with Mithra Pharmaceuticals, said, “The campus is well-positioned to address the current challenges of the Indian pharma industry both in terms of infrastructure and collaborative eco-system. The campus will act as the access point for Indian pharma companies to enter the European market and increase their business and value proposition.”
Valerie Gordenne, CSO, Mithra Pharmaceuticals, said, “We are GMP and cGMP compliant and we have the know-how to offer regulatory support to the Indian companies to enter the European market. We definitely want to collaborate on the research level as well.”
The company, once it ties-up with Indian companies, expects to launch contraceptive products in the Indian market followed by oncology and other products. “The first line of product is likely to be contraceptive and then may be oncology, in breast-cancer and cervical cancer space. We may then look at menopausal and other lines of products,” said Garrick Colle of Mithra
Source: http://www.mydigitalfc.com/news/mithra-seeks-distribution-partners-india-870
No comments:
Post a Comment